Spravato vs TMS: Which Depression Treatment Is Right for You?

According to a 2025 individual participant data analysis published in eClinicalMedicine (The Lancet), intranasal esketamine does not appear to be more effective than TMS for treatment-resistant depression; TMS was found to be similarly effective, or potentially even superior, to Spravato across key outcomes. That is a striking finding, especially for patients who assume a medication-based […]